BlackRock, Inc. 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-25 6:35 pm Sale |
2025-03-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
2,306,622 1.700% |
-146,427 (-5.97%) |
Filing |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
2,453,049 7.100% |
549,524 (+28.87%) |
Filing |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
1,903,525 5.500% |
102,056 (+5.67%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
1,801,469 6.100% |
417,488 (+30.17%) |
Filing |
| 2021-02-02 3:16 pm Purchase |
2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
1,383,981 5.600% |
1,383,981 (New Position) |
Filing |